Lifco AB (publ) LIFCO-B.ST
Composite 49/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 36/100 — a moderate mark against it.
Quality ranks 57/100 — a slight point in its favour. Growth ranks 54/100 — a slight point in its favour.
Valuation ranks 36/100 — a moderate mark against it. Momentum ranks 48/100 — a slight mark against it. Balance-sheet strength ranks 48/100 — a slight mark against it.
What the company does Lifco AB (publ) operates in three segments: dental equipment and consumables, demolition robots and attachments, and systems solutions for electrical installations and infrastructure. Its diversified portfolio spans Europe, North America, and Asia, serving dental labs, construction, and industrial end-markets.
Key financials Lifco reports strong profitability with ROE 20.2%, ROA 8.2%, and ROCE 17.4%. Margins are healthy: gross 44.1%, operating 19.3%, net 13.2%. Revenue and EPS growth stand at 10.8% and 17.8%, respectively, with a Piotroski F-Score of 8/9.
Stock health The stock shows mixed momentum: +10.76% over 3 months, +3.08% over 6 months, but -7.78% over 12 months. It is -16.52% below its 52-week high, with RSI(14) at 53.60, indicating neutral momentum.
Price vs fair value Lifco trades at a **PREMIUM of 47.40%** versus our fair-value estimate of 168.89 and at a **discount of 9.14%** versus the 12-month analyst target of 350.57. - High forward P/E of 36.23 and PEG of 7.16 signal valuation concerns (Valuation 34.5/100). - Strong quality scores (Quality 68.3) and growth (Growth 61.8) justify premium pricing. - Net margins of 13.2% and ROE of 20.2% reflect operational strength. - Debt/Equity of 0.58 and interest coverage of 14.32 indicate manageable leverage.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.